FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311755002> ?p ?o ?g. }

• W4311755002 abstract "Abstract Background Montefiore Medical Center (MMC), Bronx, NY, established an ambulatory program to offer COVID-19 treatments (monoclonal antibodies [mAB] and oral antivirals) to patients with mild-moderate illness according to emergency use authorization criteria. Given multiple pandemic waves in the area, several patients have been reinfected and were treated twice. The objective of this analysis is to identify clinical characteristics and outcomes in patients with repeated COVID-19 infections and treatments. Methods Electronic health records were reviewed to identify patients between December 1, 2020 and April 28, 2022 who received COVID-19 treatment on more than one occasion at MMC. Data collected included demographics, risk factors for progression to severe illness, name and date of COVID-19 treatments received, vaccination status, and clinical outcomes of 30-day emergency department (ED) presentation or hospital admission following each treatment. Results Out of 3,042 total treated patients, 13 (0.4%) received multiple treatments with either mAB or oral antivirals for COVID-19 reinfection during the study period. Median age of reinfected patients requiring treatment was 50 years. Median days between first and second treatments was 298 days (range 91-468 days). The most common risk factor for progression to severe disease were cardiovascular disease (54%) and immunocompromised status (62%) (Table 1). Ten patients had received at least two doses of vaccine (77%) with Pfizer (54%) or Moderna (23%) vaccines prior to reinfection. No patients reported any adverse reactions to either treatment. Four patients presented to the ED or were hospitalized following treatment of reinfection, three of which were for COVID-related symptoms. Of these, two had two risk factors for progression and the third had been hospitalized previously for initial COVID-19 infection. Conclusion Though COVID-19 reinfection has been described, especially during Omicron surges, there were relatively few reinfected patients requiring treatment in our cohort. Patients with risk factors for disease progression may also be at increased risk for reinfection, especially the immunocompromised. Disclosures Kelsie Cowman, MPH, Merck: Grant/Research Support Yi Guo, PharmD, BCIDP, Merck: Grant/Research Support." @default.
• W4311755002 created "2022-12-28" @default.
• W4311755002 creator A5015702765 @default.
• W4311755002 creator A5022557838 @default.
• W4311755002 creator A5030501058 @default.
• W4311755002 creator A5064103282 @default.
• W4311755002 creator A5066863752 @default.
• W4311755002 creator A5071058547 @default.
• W4311755002 creator A5072849182 @default.
• W4311755002 date "2022-12-01" @default.
• W4311755002 modified "2023-10-14" @default.
• W4311755002 title "1867. Characteristics and Outcomes of Patients with SARS-CoV-2 Reinfections Requiring Treatment in a COVID-19 Ambulatory Treatment Program" @default.
• W4311755002 doi "https://doi.org/10.1093/ofid/ofac492.1496" @default.
• W4311755002 hasPublicationYear "2022" @default.
• W4311755002 type Work @default.
• W4311755002 citedByCount "0" @default.
• W4311755002 crossrefType "journal-article" @default.
• W4311755002 hasAuthorship W4311755002A5015702765 @default.
• W4311755002 hasAuthorship W4311755002A5022557838 @default.
• W4311755002 hasAuthorship W4311755002A5030501058 @default.
• W4311755002 hasAuthorship W4311755002A5064103282 @default.
• W4311755002 hasAuthorship W4311755002A5066863752 @default.
• W4311755002 hasAuthorship W4311755002A5071058547 @default.
• W4311755002 hasAuthorship W4311755002A5072849182 @default.
• W4311755002 hasBestOaLocation W43117550021 @default.
• W4311755002 hasConcept C118552586 @default.
• W4311755002 hasConcept C126322002 @default.
• W4311755002 hasConcept C187212893 @default.
• W4311755002 hasConcept C194828623 @default.
• W4311755002 hasConcept C195910791 @default.
• W4311755002 hasConcept C197934379 @default.
• W4311755002 hasConcept C203014093 @default.
• W4311755002 hasConcept C22070199 @default.
• W4311755002 hasConcept C2779134260 @default.
• W4311755002 hasConcept C2780724011 @default.
• W4311755002 hasConcept C3008058167 @default.
• W4311755002 hasConcept C35785553 @default.
• W4311755002 hasConcept C524204448 @default.
• W4311755002 hasConcept C71924100 @default.
• W4311755002 hasConceptScore W4311755002C118552586 @default.
• W4311755002 hasConceptScore W4311755002C126322002 @default.
• W4311755002 hasConceptScore W4311755002C187212893 @default.
• W4311755002 hasConceptScore W4311755002C194828623 @default.
• W4311755002 hasConceptScore W4311755002C195910791 @default.
• W4311755002 hasConceptScore W4311755002C197934379 @default.
• W4311755002 hasConceptScore W4311755002C203014093 @default.
• W4311755002 hasConceptScore W4311755002C22070199 @default.
• W4311755002 hasConceptScore W4311755002C2779134260 @default.
• W4311755002 hasConceptScore W4311755002C2780724011 @default.
• W4311755002 hasConceptScore W4311755002C3008058167 @default.
• W4311755002 hasConceptScore W4311755002C35785553 @default.
• W4311755002 hasConceptScore W4311755002C524204448 @default.
• W4311755002 hasConceptScore W4311755002C71924100 @default.
• W4311755002 hasIssue "Supplement_2" @default.
• W4311755002 hasLocation W43117550021 @default.
• W4311755002 hasOpenAccess W4311755002 @default.
• W4311755002 hasPrimaryLocation W43117550021 @default.
• W4311755002 hasRelatedWork W2006651760 @default.
• W4311755002 hasRelatedWork W2018940426 @default.
• W4311755002 hasRelatedWork W2025193597 @default.
• W4311755002 hasRelatedWork W2026095104 @default.
• W4311755002 hasRelatedWork W2211558114 @default.
• W4311755002 hasRelatedWork W2422785280 @default.
• W4311755002 hasRelatedWork W2886175927 @default.
• W4311755002 hasRelatedWork W3216609493 @default.
• W4311755002 hasRelatedWork W4225372502 @default.
• W4311755002 hasRelatedWork W4255390422 @default.
• W4311755002 hasVolume "9" @default.
• W4311755002 isParatext "false" @default.
• W4311755002 isRetracted "false" @default.
• W4311755002 workType "article" @default.